ScoreWhy is Medexus Pharmaceuticals, Inc. ?
1
- NET PROFIT(Q) At CAD 1.39 MM has Fallen at -60.51%
- ROCE(HY) Lowest at 1.88%
- INVENTORY TURNOVER RATIO(HY) Lowest at 1.45%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Medexus Pharmaceuticals, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Medexus Pharmaceuticals, Inc.
-28.57%
0.05
67.45%
S&P/TSX 60
18.99%
1.54
14.62%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
11.17%
EBIT Growth (5y)
26.54%
EBIT to Interest (avg)
0.69
Debt to EBITDA (avg)
3.02
Net Debt to Equity (avg)
0.25
Sales to Capital Employed (avg)
1.36
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
10.66%
ROE (avg)
4.69%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
1.24
EV to EBIT
9.84
EV to EBITDA
4.79
EV to Capital Employed
1.20
EV to Sales
0.72
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
12.15%
ROE (Latest)
6.27%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
DEBT-EQUITY RATIO
(HY)
Lowest at 23.72 %
RAW MATERIAL COST(Y)
Fallen by -5.44% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 8.42%
-18What is not working for the Company
NET PROFIT(Q)
At CAD 1.39 MM has Fallen at -60.51%
ROCE(HY)
Lowest at 1.88%
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.45%
PRE-TAX PROFIT(Q)
At CAD 1.66 MM has Fallen at -51.86%
NET SALES(Q)
Lowest at CAD 34.06 MM
Here's what is working for Medexus Pharmaceuticals, Inc.
Debt-Equity Ratio
Lowest at 23.72 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Debtors Turnover Ratio
Highest at 8.42%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -5.44% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Medexus Pharmaceuticals, Inc.
Net Profit
At CAD 1.39 MM has Fallen at -60.51%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (CAD MM)
Pre-Tax Profit
At CAD 1.66 MM has Fallen at -51.86%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CAD MM)
Inventory Turnover Ratio
Lowest at 1.45% and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Net Sales
Lowest at CAD 34.06 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CAD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
